Malignant eccrine hidradenoma.
Cauthon DJ, Worthen T, Freed L, DeComas AM.
J Am Podiatr Med Assoc. 2013 Jul-Aug;103(4):333-6. doi: 10.7547/1030333.
Poroid hidradenoma: a benign lesion masking as a malignant breast tumor.
Liaqat H, Ammad Ud Din M, Malik D.
QJM. 2020 Oct 1;113(10):749-750. doi: 10.1093/qjmed/hcaa109.
Lymph Node Involvement by a Clear Cell Nodular Hidradenoma-Like Tumor of Uncertain Malignant Potential.
Au B, Sidiropoulos KG, Ghazarian D, Sidiropoulos M.
Am J Dermatopathol. 2017 Dec;39(12):953-954. doi: 10.1097/DAD.0000000000000808.
Hidradenocarcinoma.
de Lima AA, Santos M, de Morais PM, Rodrigues CAC.
An Bras Dermatol. 2021 Mar-Apr;96(2):251-253. doi: 10.1016/j.abd.2020.03.023. Epub 2021 Feb 5.
Clear-cell hidradenoma.
AZZOPARDI JG.
J Pathol Bacteriol. 1958 Oct;76(2):379-82. doi: 10.1002/path.1700760206.
[Nodular hidradenoma].
Soua Y, Mohamed M, Belhajali H, Njim L, Youssef M, Zakhama A, Zili J.
Ann Dermatol Venereol. 2013 Feb;140(2):152-3. doi: 10.1016/j.annder.2012.11.002. Epub 2012 Dec 28.
Incidence, survival, and prognostic factors associated with malignant nodular hidradenoma in the United States.
Ugwu N, Cheraghlou S, Ko CJ, Cohen JM.
J Am Acad Dermatol. 2023 Apr;88(4):875-877. doi: 10.1016/j.jaad.2022.09.053. Epub 2022 Oct 11.
[Nodular hidradenoma].
Espejo Pérez I, Querol Gutiérrez JJ, Vílchez Márquez F.
Semergen. 2017 Sep;43(6):475-476. doi: 10.1016/j.semerg.2016.10.002. Epub 2016 Dec 16.
[Hidradenoma papilliferum].
Elouarradi R, Hocar O.
Pan Afr Med J. 2014 Apr 14;17:274. doi: 10.11604/pamj.2014.17.274.4177. eCollection 2014.
[Poroid hidradenoma].
Monteagudo B, Iglesias B, de la Torre C, Paredes C, Vázquez-Blanco M, Ginarte M, Labandeira J.
Actas Dermosifiliogr. 2005 Jul-Aug;96(6):398-9. doi: 10.1016/s0001-7310(05)73100-8.
